3 Things You (Still) Need to Know About GLP-1 Agonists
July 8, 2015
Incretin mimetic therapy for type 2 diabetes has been on the market for more than 10 years. Find out what you've learned about the GLP-1 agonists, here.
Diabetes Type 2
Abridged Diabetes Guidelines for Primary Care: 6 Noteworthy Changes
April 27, 2015
The ADA provides an abridged version for PCPs of its annual Standards of Medical Care. Our slides summarize 6 updates important to primary care.
FDA Approves New Anti-Obesity Drug
September 23, 2014
Contrave, a combination of naltrexone and buproprion, has been approved for long-term weight loss management in overweight and obese adults.
SGLT2 Inhibitors: 4 Points on Efficacy, Safety You Need to Know
August 19, 2014
Studies looking at add-on treatment with SGLT2 inhibitors show their effects on glycemic control to be roughly additive. Here, a concise look at clinical trial results plus guidance on renal dose adjustment.
Initial Combination Therapy for Type 2 Diabetes: Hit It Early and Hit It Hard?
August 28, 2012
Early use of combination therapy to treat type 2 diabetes is shown to limit glucose toxicity and preserve beta-cell function.
